📍 Friday, October 24, 2025, from 9am to 1.30pm – Aula Magna, Faculty of Pharmacy and Food Sciences, Campus Diagonal, University of Barcelona
This conference brings together leading researchers and clinicians to explore the most recent advances in psychedelic science — from preclinical discoveries to therapeutic applications.
Coordinated by Dr. Elisabet Domínguez-Clavé and Dr. Raúl López-Arnau
In order to register, please fill out the form at the bottom of this page. Admission is free.
PROGRAMM
09:15 – 09:30 Opening Remarks – Dr. Jordi Camarasa, Dean of the Faculty of Pharmacy
09:30 – 10:30 Preclinical Research on Psychedelics
Advances in Preclinical Psychedelic Research – Clara Riera, PhD Student, University of Barcelona
Exploring New Psychedelic Molecules: The Therapeutic Potential of Phenethylamines and DMT Derivatives in Depression – Dr. Núria Nadal-Gratacós, Lecturer, University of Barcelona
10:30 – 11:00 Clinical Research on Psychedelics (I)
5-MeO-DMT and Psychedelic-Assisted Therapy in Treatment-Resistant Major Depression – Dr. Rosa Maria Dueñas, Psychiatrist & Researcher, ANIMA Group, Parc Sanitari Sant Joan de Déu
11:00 – 11:30 Coffee Break
11:30 – 12:30 Clinical Research on Psychedelics (II)
Ibogaine for the Treatment of Substance Use Disorders: From Mechanisms to Clinical Efficacy – Dr. Genís Oña, Psychologist & Researcher, Sant Joan de Déu Research Institute (IRSJD), Universitat Rovira i Virgili
Promises and Challenges of Psilocybin in the Treatment of Depression – Dr. Santiago Madero, Psychiatrist & Researcher, Hospital Clínic de Barcelona, IDIBAPS
12:30 – 13:15 Roundtable
Cross-questions between Preclinical and Clinical Researchers
13:15 – 13:30 Closing Session
Presentation of the European Citizens’ Initiative PsychedeliCare & Closing Remarks
